TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biogen Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
602,723
|
646,870
|
643,769 |
| Financial expenses |
26
|
82
|
403 |
| Earnings before taxes |
23,936
|
24,796
|
22,698 |
| EBITDA |
22,424
|
23,027
|
23,363 |
| Total assets |
268,087
|
256,071
|
236,962 |
| Current assets |
267,652
|
255,880
|
236,619 |
| Current liabilities |
51,367
|
60,949
|
72,384 |
| Equity capital |
203,845
|
182,228
|
152,385 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
23
|
28
|
31 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.0%
|
71.2%
|
64.3% |
| Turnover per employee |
26,205
|
23,102
|
20,767 |
| Profit as a percentage of turnover |
4.0%
|
3.8%
|
3.5% |
| Return on assets (ROA) |
8.9%
|
9.7%
|
9.7% |
| Current ratio |
521.1%
|
419.8%
|
326.9% |
| Return on equity (ROE) |
11.7%
|
13.6%
|
14.9% |
| Change turnover |
-55,811
|
-42,579
|
-79,078 |
| Change turnover % |
-8%
|
-6%
|
-11% |
| Chg. No. of employees |
-5
|
-3
|
0 |
| Chg. No. of employees % |
-18%
|
-10%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.